Page 4 - Heart Failure Protocols
P. 4

Pediatric Heart Failure Guidelines

               Table of Contents

               Preface ...................................................................................................................................... 3
               Heart Failure - General Considerations ...................................................................................... 6
                  Heart Failure - Initial Evaluation .............................................................................................. 6
                  Heart Failure Disease Staging for Infants & Children .............................................................. 6
                  Heart Failure Symptom Severity Classification ....................................................................... 7
                  Heart Failure Medications ....................................................................................................... 8
                  Heart Failure Anticoagulation ................................................................................................11
                  Heart Failure Nutrition ...........................................................................................................11
                  Heart Failure Exercise ...........................................................................................................12
                  Heart Failure Advanced Therapies ........................................................................................13
                  Heart Failure Follow-up Schedule ..........................................................................................14
               Dilated Cardiomyopathy (DCM) ................................................................................................14

                  Additional Evaluation for DCM ...............................................................................................14
                  Medical Management DCM ...................................................................................................14
                  Follow-up Schedule for DCM .................................................................................................15
               Restrictive Cardiomyopathy (RCM) ...........................................................................................15

                  Additional Evaluation for RCM ...............................................................................................15
                  Medical Management RCM ...................................................................................................15
                  Follow-up Schedule for Restrictive Cardiomyopathy ..............................................................15
               Hypertrophic Cardiomyopathy (HCM) .......................................................................................16

                  Additional Evaluation for HCM ...............................................................................................16
                  Management HCM ................................................................................................................16
                  Follow-up Schedule for Hypertrophic Cardiomyopathy ..........................................................17

               Non-Compaction Cardiomyopathy (LVNC) ................................................................................17
                  Additional Evaluation for LVCN .............................................................................................17
                  Medical Management for LVCN .............................................................................................18
                  Follow-up Schedule for LVCN ...............................................................................................18

               Congenital Heart Disease with Heart Failure .............................................................................18
                  Additional Evaluation for CHD with Heart Failure ...................................................................18
                  Management and Long-Term Follow-up for CHD with Heart Failure ......................................18
               Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) ......................................................18
                  Additional Evaluation for ARVC .............................................................................................18
                  Medical Management for ARVC ............................................................................................19
                  Follow up for ARVC ...............................................................................................................19
               Chemotherapy Induced Cardiomyopathy ..................................................................................19

                  Additional Evaluation for Patient with Chemotherapy Induced Cardiomyopathy ....................19
                  Medical Management Chemotherapy Induced Cardiomyopathy ............................................19
                  Follow-up Schedule for Chemotherapy Induced Cardiomyopathy ..........................................20




               Updated 3/1/2018                                                                        page 4
   1   2   3   4   5   6   7   8   9